- Home
- BY vs SPRY Comparison
BY vs SPRY Comparison
Compare BY & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- SPRY
- Stock Information
- Founded
- BY 1914
- SPRY 2015
- Country
- BY United States
- SPRY United States
- Employees
- BY N/A
- SPRY N/A
- Industry
- BY Major Banks
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- BY Finance
- SPRY Health Care
- Exchange
- BY Nasdaq
- SPRY Nasdaq
- Market Cap
- BY 1.1B
- SPRY 1.2B
- IPO Year
- BY 2017
- SPRY N/A
- Fundamental
- Price
- BY $26.24
- SPRY $13.44
- Analyst Decision
- BY Hold
- SPRY Strong Buy
- Analyst Count
- BY 3
- SPRY 4
- Target Price
- BY $33.67
- SPRY $28.75
- AVG Volume (30 Days)
- BY 161.2K
- SPRY 1.2M
- Earning Date
- BY 04-24-2025
- SPRY 05-14-2025
- Dividend Yield
- BY 1.53%
- SPRY N/A
- EPS Growth
- BY N/A
- SPRY N/A
- EPS
- BY 2.69
- SPRY 0.08
- Revenue
- BY $379,386,000.00
- SPRY $89,149,000.00
- Revenue This Year
- BY $14.38
- SPRY $1.49
- Revenue Next Year
- BY $5.04
- SPRY $141.68
- P/E Ratio
- BY $9.80
- SPRY $168.31
- Revenue Growth
- BY 3.48
- SPRY 297063.34
- 52 Week Low
- BY $21.96
- SPRY $7.55
- 52 Week High
- BY $32.89
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- BY 56.50
- SPRY 46.69
- Support Level
- BY $25.57
- SPRY $13.06
- Resistance Level
- BY $26.61
- SPRY $15.06
- Average True Range (ATR)
- BY 0.60
- SPRY 0.67
- MACD
- BY 0.19
- SPRY -0.18
- Stochastic Oscillator
- BY 85.35
- SPRY 15.97
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.